This paper examines the nature of compliance, and its role within the modern financial services organisation. Defining compliance as the management of regulatory risk, the paper analyses what those risks are, and outlines the process by which firms should seek to manage that risk. It concludes by outlining the possible benefits of such an approach.
If you would like to write for this, or any other Emerald publication, then please use our Emerald for Authors service information about how to choose which publication to write for and submission guidelines are available for all. Please visit www.emeraldinsight.com/authors for more information.
About Emerald www.emeraldinsight.comEmerald is a global publisher linking research and practice to the benefit of society. The company manages a portfolio of more than 290 journals and over 2,350 books and book series volumes, as well as providing an extensive range of online products and additional customer resources and services.Emerald is both COUNTER 4 and TRANSFER compliant. The organization is a partner of the Committee on Publication Ethics (COPE) and also works with Portico and the LOCKSS initiative for digital archive preservation. ABSTRACT This paper considers the obstacles to the regulation of financial conglomerates and the events that have shaped thinking at the regulators, in particular in the banking context. In the light of the Barings debacle in particular it identifies some of the issues that such financial institutions raise for financial systems and the authorities, concluding with the challenges faced by national regulators in an increasingly global environment and what needs to be put in place to meet those challenges.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.